Covered recipient · General Payments record
CLAUDIA GABRIELA GIDEA
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$9,445.98
- Reported across 84 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,702.06 | 31 |
| Consulting Fee | $2,200.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Maquet Cardiovascular L.L.C. | $2,200.00 | 1 |
| CVRx Inc. | $695.42 | 6 |
| ABIOMED | $657.74 | 6 |
| Paragonix Technologies, Inc. | $400.85 | 4 |
| Abbott Laboratories | $368.14 | 7 |
| Daxor Corporation | $203.12 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $146.93 | 1 |
| ShockWave Medical, Inc | $100.00 | 1 |
| iRhythm Technologies, Inc. | $53.75 | 1 |
| ATRICURE, INC. | $40.59 | 1 |
| Alnylam Pharmaceuticals Inc. | $19.83 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $151.16 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125006007 | CMS |
| Abbott Laboratories | $11.77 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125006014 | CMS |
| Abbott Laboratories | $24.97 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125006022 | CMS |
| Abbott Laboratories | $12.99 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125006030 | CMS |
| Abbott Laboratories | $10.45 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125006039 | CMS |
| Abbott Laboratories | $16.11 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125006047 | CMS |
| Abbott Laboratories | $140.69 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125006053 | CMS |
| ABIOMED | $49.15 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142224668 | CMS |
| ABIOMED | $115.62 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142224700 | CMS |
| ABIOMED | $95.96 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142224720 | CMS |
| ABIOMED | $118.99 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142224749 | CMS |
| ABIOMED | $134.37 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142224753 | CMS |
| ABIOMED | $143.65 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142224755 | CMS |
| Alnylam Pharmaceuticals Inc. | $19.83 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125836789 | CMS |
| ATRICURE, INC. | $40.59 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132889716 | CMS |
| Boston Scientific Corporation | $146.93 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092268448 | CMS |
| CVRx, Inc. | $162.93 | 01/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128562288 | CMS |
| CVRx, Inc. | $196.07 | 01/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128562290 | CMS |
| CVRx, Inc. | $180.96 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124770250 | CMS |
| CVRx, Inc. | $107.69 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124770246 | CMS |
| CVRx, Inc. | $15.83 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124770248 | CMS |
| CVRx, Inc. | $31.94 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128562292 | CMS |
| Daxor Corporation | $101.56 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136816149 | CMS |
| Daxor Corporation | $101.56 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136816152 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.69 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101423894 | CMS |
| iRhythm Technologies, Inc. | $53.75 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154055698 | CMS |
| Maquet Cardiovascular L.L.C. | $2,200.00 | 04/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1149640364 | CMS |
| Paragonix Technologies, Inc. | $240.81 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101026268 | CMS |
| Paragonix Technologies, Inc. | $142.92 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101027088 | CMS |
| Paragonix Technologies, Inc. | $1.86 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101027090 | CMS |
| Paragonix Technologies, Inc. | $15.26 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101027092 | CMS |
| ShockWave Medical, Inc | $100.00 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152978283 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.